Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Deucravacitinib may effectively treat discoid lupus erythematosus.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Congenital triangular alopecia and vitiligo can occur together, but treatment for one may not affect the other.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Oral tofacitinib successfully treated total body hair loss in one patient.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.